Role of Cognitive Processes in Immuno-Modulation in Cancer Disease
Paul Ehrlich in 1909 recognized that an intact immune system was a requisite for maintenance of host resistance against neoplasia (1). This concept, refined by Burnet (2), postulated that T-lymphocytes recognize and monitor antigenic changes accompanying malignant transformations. Although substantial amount of evidence supports immune surveillance, other data place its validity in doubt (3). However, there is a common opinion among tumor immunologists that antitumor reactivity of immune lymphocytes is dependent principally upon cytotoxic T cells that recognize tumor-associated antigens in conjunction with histocompatibility complex antigens in cell membranes of antigen-presenting cells (macrophages, dendritic cells).
KeywordsImmune Parameter Psychological Response Peripheral Lymph Node Anger Control Antigenic Change
Unable to display preview. Download preview PDF.
- 1.P. Ehrlich, Uber den jetzigen Stand der Karzinomforschung. Ned. Tijdschr. Geneesk 5:273–290 (1909).Google Scholar
- 3.S. Sell, Tumor immunity. In: “Immunology, Immunopathology and Immunity,” 4th ed., pp. 725–786. Elsevier, New York, 1987.Google Scholar
- 5.W.A. Blattner and R.N. Hoover, Cancer in the immonusupressed host. In: “Cancer: Principles and Practice of Oncology” (J.T. DeVita, Jr., S. Hellman, and S. Rosenberg, Eds.), 2nd ed., chapt. 53, pp. 1999–2006. J.B. Lippencott, Philadelphia, 1985.Google Scholar
- 6.Abstr. Commun. Neuropeptides and Immunopeptides: Messengers in a Neuroimmune axis. New York Academy of Sciences, New York, Oct. 2–4, 1989.Google Scholar
- 10.R. Grossarth-Maticek, P. Schmidt, H. Vetter, and S. Arndt, Psychotherapy research in oncology. In: “Health Care and Human Behavior” (A. Steptoe and A. Mathews, Eds.), pp. 325–340. Academic Press, London, 1984.Google Scholar
- 13.Letters to the Editor: Psychological support for cancer patients. Lancet ii:1209–1210 (1989).Google Scholar
- 14.K.S. Zanker and R.M. Kroczek, Immunophenotyping, immunointervention and depression in cancer patients. A follow-up study in five bereaved patients. Int. J. Immunother. 4:235–241 (1988).Google Scholar